Nu Skin Enterprises 

€6.7
123
+€0+0% 今天

統計

當日最高
6.7
當日最低
6.45
52週最高
-
52週最低
-
成交量
350
平均成交量
-
市值
443.84M
市盈率
-
股息收益率
7.53%
股息
0.5

即將到來

股息

7.53%股息收益率
10年增長
-13.53%
5年增長率
-26.27%
3年增長率
-40.36%
1年增長率
-79.33%

收益

30Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
-0.02
0.1
0.22
0.34
預期每股收益
0.18308762190999997
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 NUS.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

11.25平均價格目標
最高估價為 €11.5。
來自過去 6 個月內的 2 個評級。這不是投資建議。
買入
0%
持有
100%
賣出
0%

關於

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Show more...
首席執行官
Mr. Steven J. Lund
員工
3700
國家
US
ISIN
US67018T1051
WKN
000903911

上市公司